PTPRC and colorectal carcinoma: Three distinct phenotypes of CTCs were identified in patients with stage III/IV CRC, namely CSV-CTCs (vimentin + CD45-PanCK-), PanCK-CTCs (vimentin- CD45-PanCK +), and Mixed-CTCs (vimentin + CD45-PanCK +) (Fig. 1A).